Michael He, Ph.D., BPharm (Hons)

442 posts

Michael He, Ph.D., BPharm (Hons) banner
Michael He, Ph.D., BPharm (Hons)

Michael He, Ph.D., BPharm (Hons)

@themichaelhe

Study #lymphoma, #epigenetics, #protac, #immune @PMcancercentre🇨🇦 | Founder @UHNPostdocs | Delegate @OICRRisingStars | Alum @PeterMacCC🇦🇺

Toronto, Ontario Beigetreten Mayıs 2021
291 Folgt234 Follower
Angehefteter Tweet
Michael He, Ph.D., BPharm (Hons)
Michael He, Ph.D., BPharm (Hons)@themichaelhe·
Targeting epigenetic disruptions in cancer holds promise. Our latest paper in @LeukemiaJnl reveals a novel viral mimicry-interferon mechanism enhancing HDAC3 inhibition in GNAS knockout lymphoma. Proud to lead this challenging project with an amazing team! nature.com/articles/s4137…
English
2
2
14
1.5K
Michael He, Ph.D., BPharm (Hons) retweetet
Mark Dawson
Mark Dawson@MAF_Dawson·
We are looking for a talented postdoctoral bioinformatician ⁦@TheDawsonLab⁩ to work with us on single cell multiomics incorporating lineage tracing and spatial technologies- we specifically want someone curious, fearless with a licence to innovate!! nature.com/naturecareers/…
English
1
24
65
7K
Michael He, Ph.D., BPharm (Hons) retweetet
Brian Liau
Brian Liau@brian_b_liau·
Today in @Nature we share our back-to-back stories with @nzhenguw revealing chemical-genetic convergence between a molecular glue & E3 ligase cancer mutations. 1/6
Brian Liau tweet media
English
11
93
500
90.6K
Michael He, Ph.D., BPharm (Hons)
Michael He, Ph.D., BPharm (Hons)@themichaelhe·
I know I must read this masterpiece when I see @MAF_Dawson! Very happy to see a comprehensive review on the hallmarks of cancer - an epigenetic perspective. Thank you to all the authors.
Elizabeth McKenna@ElizSMcKenna

🥁Out today in the October issue of @CD_AACR: ⭐️The Epigenetic Hallmarks of Cancer⭐️ - by @ManelEsteller, @MAF_Dawson, @CKadoch, Feyruz Rassool, Peter Jones, and Steve Baylin doi.org/10.1158/2159-8…

English
1
0
7
685
Michael He, Ph.D., BPharm (Hons) retweetet
Michael Green, PhD
Michael Green, PhD@GreenLymphoLab·
Transcriptional/epigenetic chemical inducers of proximity (TCIPs) are an innovative new class of therapeutics that are set to impact lymphoma and other malignancies. Here @RomanSarott, @saigourisankar describe a CDK9 "catch and release" MOA for a new TCIP. science.org/doi/10.1126/sc…
English
0
2
16
1.2K
Michael He, Ph.D., BPharm (Hons)
Michael He, Ph.D., BPharm (Hons)@themichaelhe·
Excited to kick off the fight against #lymphoma with a first score! Honored to work with Dr. Kridel and a great team for these achievements. As Michael Jordan said, 'Talent wins games, but teamwork and intelligence wins championships.' Here’s to more victories in cancer research!
UHN Research@UHN_Research

As #BloodCancerAwarenessMonth wraps up, we want to congratulate @PMResearch_UHN’s Dr. Robert Kridel @rkridel for publishing three new studies on #lymphoma. Read about his team’s dedication to advancing cancer research using genetic analysis. 🔗uhnresearch.ca/news/cracking-… @UHN

English
0
0
1
115
Michael He, Ph.D., BPharm (Hons)
Michael He, Ph.D., BPharm (Hons)@themichaelhe·
As Chair of the Program Committee for the 1st UHN Postdoc Symposium last year, I know how much effort goes into these events. Great job to the current team on the 2nd! Highly recommend all UHN postdocs join to get inspired and connect. Register now!
UHN Postdoc Association (UHNPA)@UHNPostdocs

🚨 Two-week countdown to our 2nd Annual UHN Postdoc Symposium! 🗓️September 18, 2024 📍Room 2-014, Toronto Rehab Institute Join us to meet the distinguished panelists and explore success beyond a PhD. Free for UHN postdocs, students, PIs, and staff!

English
0
0
3
204
Michael He, Ph.D., BPharm (Hons)
Michael He, Ph.D., BPharm (Hons)@themichaelhe·
Targeting epigenetic disruptions in cancer holds promise. Our latest paper in @LeukemiaJnl reveals a novel viral mimicry-interferon mechanism enhancing HDAC3 inhibition in GNAS knockout lymphoma. Proud to lead this challenging project with an amazing team! nature.com/articles/s4137…
English
2
2
14
1.5K
Michael He, Ph.D., BPharm (Hons)
Michael He, Ph.D., BPharm (Hons)@themichaelhe·
How does mimicking a viral infection in cancer cells boost epigenetic therapy and anti-tumor immunity? 🧬 Check out our latest blog on targeting HDAC3 in lymphoma! 💡 👉 Read more communities.springernature.com/posts/gnas-kno… #CancerResearch #Epigenetics #Lymphoma #HDAC3 #ViralMimicry #Oncology
Michael He, Ph.D., BPharm (Hons)@themichaelhe

Targeting epigenetic disruptions in cancer holds promise. Our latest paper in @LeukemiaJnl reveals a novel viral mimicry-interferon mechanism enhancing HDAC3 inhibition in GNAS knockout lymphoma. Proud to lead this challenging project with an amazing team! nature.com/articles/s4137…

English
0
0
3
187
Michael He, Ph.D., BPharm (Hons) retweetet
Andrew M. Evens, DO, MBA, MSc
Andrew M. Evens, DO, MBA, MSc@DrAEvens·
👏👏 Super kudos to @pmcancercentre @rkridel for this outstanding translational work in follicular #lymphoma. From 713 tumor tissue samples (eg, E4402, E2408 & GALLIUM), 5 genetic subtypes discovered and a/w clinicopath findings & pt outcomes. 👉👉 SEE: rdcu.be/dQmEk
Andrew M. Evens, DO, MBA, MSc tweet mediaAndrew M. Evens, DO, MBA, MSc tweet mediaAndrew M. Evens, DO, MBA, MSc tweet mediaAndrew M. Evens, DO, MBA, MSc tweet media
English
1
13
36
4.7K

Entdecken

@TheDawsonLab @Nature @nzhenguw @R_Infosource @Stanford @ScienceMagazine @Stanford_ChEMH @StanfordCancer